Search

Your search keyword '"Bouaziz, Jean‐David"' showing total 751 results

Search Constraints

Start Over You searched for: Author "Bouaziz, Jean‐David" Remove constraint Author: "Bouaziz, Jean‐David"
751 results on '"Bouaziz, Jean‐David"'

Search Results

1. Early elevated IFNα is a key mediator of HIV pathogenesis

3. Pasteurella bettyae Infections in Men Who Have Sex with Men, France

4. French protocol for the diagnosis and management of systemic lupus erythematosus

5. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

6. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study

7. Coencapsulation of Immunosuppressive Drug with Anti-Inflammatory Molecule in Pickering Emulsions as an Innovative Therapeutic Approach for Inflammatory Dermatoses

10. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

11. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

13. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients

14. Epidermal renewal during the treatment of atopic dermatitis lesions: A study coupling line‐field confocal optical coherence tomography with artificial intelligence quantifications: LC‐OCT reveals new biological markers of AD.

15. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms

16. Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides

17. “Co-encapsulation of Immunosuppressive Drug with Anti-inflammatory Molecule in Pickering Emulsions as a Novel Therapeutic Approach for Inflammatory Dermatoses”

20. Somatic Mosaic NLRP3 Mutations and Inflammasome Activation in Late-Onset Chronic Urticaria

22. Perspective to precision medicine in scleroderma

23. Two cases of Dupilumab responsive Kimura disease

25. Transcriptomic Landscape of Prurigo Nodularis Lesional Skin CD3+ T Cells Using Single-Cell RNA Sequencing

26. Microenvironment tailors nTreg structure and function

27. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores

28. Two cases of dupilumab-responsive Kimura disease.

32. Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome

33. Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients

35. Primary cutaneous follicle center lymphoma with secondary systemic evolution

36. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas

38. Pasteurella bettyae Infections in Men Who Have Sex with Men, France.

41. Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib

42. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis

43. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

44. Perspective to precision medicine in scleroderma.

45. Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients.

47. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease

48. Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers

49. IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy

50. Efficacity and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients

Catalog

Books, media, physical & digital resources